Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Peikwen Cheng"'
Autor:
Wing Lam, Mohammad Arammash, Wei Cai, Fulan Guan, Zaoli Jiang, Shwu-Huey Liu, Peikwen Cheng, Yung-Chi Cheng
Publikováno v:
Frontiers in Pharmacology, Vol 14 (2023)
Introduction: Prostate cancer is the second leading cause of cancer death among men in the United States. Castration-Resistant Prostate Cancer (CRPC) often develops resistance to androgen deprivation therapy. Resistance in CRPC is often driven by AR
Externí odkaz:
https://doaj.org/article/346c166ea134490baec8ca16f0874b74
Publikováno v:
Frontiers in Pharmacology, Vol 13 (2023)
YIV-906 is a systems biology botanical cancer drug, inspired by a traditional Chinese herbal formulation. Results from eight Phase I/II to II clinical studies demonstrated the potential of YIV-906 to prolong survival and improve the quality of life o
Externí odkaz:
https://doaj.org/article/d407c505ecb64045ab0107b26d089c0f
Autor:
Xiaochen Yang, Wing Lam, Zaoli Jiang, Fulan Guan, Xue Han, Rong Hu, Wei Cai, William Cheng, Shwu-Huey Liu, Peikwen Cheng, Yuping Cai, Nicholas J. W. Rattray, Caroline H. Johnson, Lieping Chen, Yung-Chi Cheng
Publikováno v:
Scientific Reports, Vol 11, Iss 1, Pp 1-12 (2021)
Abstract YIV-906 (PHY906) is a standardized botanical cancer drug candidate developed with a systems biology approach—inspired by a traditional Chinese herbal formulation, historically used to treat gastrointestinal symptoms including diarrhea, nau
Externí odkaz:
https://doaj.org/article/ae2979734ecc4108a42ccbc05970d901
Autor:
Jieya Wu, Baoguo Sun, Li Hou, Fulan Guan, Liyuan Wang, Peikwen Cheng, Sophia Scobell, Yung-Chi Cheng, Wing Lam
Publikováno v:
Frontiers in Pharmacology, Vol 11 (2021)
During the outbreak of the novel coronavirus disease (COVID-19), the Chinese government took a series of public health measures to tackle the outbreak and recommended six traditional Chinese medicine (TCM) evolved formulas, collectively referred to a
Externí odkaz:
https://doaj.org/article/8cb671e2e8bf420a9ca477648d597b6b
Autor:
Lam, Wing, Arammash, Mohammad, Wei Cai, Fulan Guan, Zaoli Jiang, Shwu-Huey Liu, Peikwen Cheng, Yung-Chi Cheng
Publikováno v:
Frontiers in Pharmacology; 2023, p1-13, 13p
Publikováno v:
Cancer Research. 83:3078-3078
Prostate cancer is the second leading cause of cancer death among men in the United States. Androgen or Androgen receptor (AR) targeted therapy is a strategy for the treatment of prostate cancer, however, long-term treatment with androgen deprivation
Publikováno v:
Cancer Research. 82:5533-5533
YIV-906 is a standardized botanical drug inspired by a traditional Chinese herbal formulation, historically used to treat gastrointestinal symptoms including diarrhea, nausea, and vomiting. Results from seven Phase I/II to II clinical studies suggest
Autor:
Rong Hu, William Cheng, Yuping Cai, Yung-Chi Cheng, Shwu-Huey Liu, Lieping Chen, Xiaochen Yang, Peikwen Cheng, Zaoli Jiang, Caroline H. Johnson, Xue han, Wing Lam, Fulan Guan, Nicholas J. W. Rattray, Wei Cai
Publikováno v:
Scientific Reports, Vol 11, Iss 1, Pp 1-12 (2021)
Scientific Reports
Scientific Reports
YIV-906 (PHY906) is a standardized botanical cancer drug candidate developed with a systems biology approach—inspired by a traditional Chinese herbal formulation, historically used to treat gastrointestinal symptoms including diarrhea, nausea and v
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0f870c060f3575c5bfc459c1fcf4a12f
https://doi.org/10.21203/rs.3.rs-289552/v1
https://doi.org/10.21203/rs.3.rs-289552/v1
Publikováno v:
Novel Approaches in Cancer Study. 3